RPRX logo

Royalty Pharma (RPRX) Working capital

annual working capital:

$548.52M-$564.29M(-50.71%)
December 31, 2024

Summary

  • As of today (May 21, 2025), RPRX annual working capital is $548.52 million, with the most recent change of -$564.29 million (-50.71%) on December 31, 2024.
  • During the last 3 years, RPRX annual working capital has fallen by -$2.16 billion (-79.74%).
  • RPRX annual working capital is now -79.74% below its all-time high of $2.71 billion, reached on December 31, 2021.

Performance

RPRX Working capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRPRXbalance sheet metrics

quarterly working capital:

$660.39M+$111.87M(+20.39%)
March 31, 2025

Summary

  • As of today (May 21, 2025), RPRX quarterly working capital is $660.39 million, with the most recent change of +$111.87 million (+20.39%) on March 31, 2025.
  • Over the past year, RPRX quarterly working capital has dropped by -$774.75 million (-53.98%).
  • RPRX quarterly working capital is now -80.12% below its all-time high of $3.32 billion, reached on June 30, 2022.

Performance

RPRX quarterly working capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRPRXbalance sheet metrics

Working capital Formula

Working Capital = Current Assets − Current Liabilities

RPRX Working capital Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-50.7%-54.0%
3 y3 years-79.7%-76.8%
5 y5 years+10.0%-49.4%

RPRX Working capital Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-79.7%at low-80.1%+20.4%
5 y5-year-79.7%+10.0%-80.1%+20.4%
alltimeall time-79.7%+10.0%-80.1%+32.4%

RPRX Working capital History

DateAnnualQuarterly
Mar 2025
-
$660.39M(+20.4%)
Dec 2024
$548.52M(-50.7%)
$548.52M(-12.4%)
Sep 2024
-
$626.44M(-72.8%)
Jun 2024
-
$2.30B(+60.5%)
Mar 2024
-
$1.44B(+29.0%)
Dec 2023
$1.11B(-19.8%)
$1.11B(-30.5%)
Sep 2023
-
$1.60B(-10.1%)
Jun 2023
-
$1.78B(+17.6%)
Mar 2023
-
$1.51B(+9.1%)
Dec 2022
$1.39B
$1.39B(+14.7%)
Sep 2022
-
$1.21B(-63.6%)
DateAnnualQuarterly
Jun 2022
-
$3.32B(+16.7%)
Mar 2022
-
$2.85B(+5.2%)
Dec 2021
$2.71B(+13.3%)
$2.71B(+7.4%)
Sep 2021
-
$2.52B(+4.0%)
Jun 2021
-
$2.42B(+12.2%)
Mar 2021
-
$2.16B(-9.6%)
Dec 2020
$2.39B(+379.1%)
$2.39B(-5.0%)
Sep 2020
-
$2.51B(-14.5%)
Jun 2020
-
$2.94B(+125.5%)
Mar 2020
-
$1.30B(+161.5%)
Dec 2019
$498.65M(-75.4%)
$498.65M
Dec 2018
$2.03B
-

FAQ

  • What is Royalty Pharma annual working capital?
  • What is the all time high annual working capital for Royalty Pharma?
  • What is Royalty Pharma annual working capital year-on-year change?
  • What is Royalty Pharma quarterly working capital?
  • What is the all time high quarterly working capital for Royalty Pharma?
  • What is Royalty Pharma quarterly working capital year-on-year change?

What is Royalty Pharma annual working capital?

The current annual working capital of RPRX is $548.52M

What is the all time high annual working capital for Royalty Pharma?

Royalty Pharma all-time high annual working capital is $2.71B

What is Royalty Pharma annual working capital year-on-year change?

Over the past year, RPRX annual working capital has changed by -$564.29M (-50.71%)

What is Royalty Pharma quarterly working capital?

The current quarterly working capital of RPRX is $660.39M

What is the all time high quarterly working capital for Royalty Pharma?

Royalty Pharma all-time high quarterly working capital is $3.32B

What is Royalty Pharma quarterly working capital year-on-year change?

Over the past year, RPRX quarterly working capital has changed by -$774.75M (-53.98%)
On this page